Actavis has appointed the board of directors for the division it recently created as part of its acquisition of Ireland-based Warner Chilcott, the drug maker said.
Ireland's High Court has approved Actavis' acquisition of Warner Chilcott, the drug makers said.
Actavis and Warner Chilcott announced that they have each received a request for additional information from the Federal Trade Commission in connection with Actavis' pending acquisition of Warner Chilcott.
Actavis will acquire Warner Chilcott for $8.5 billion, the drug maker said.
Actavis is looking into the possibility of buying Warner Chilcott, the generic drug maker said.